In Vivo ERK1/2 Reporter Predictively Models Response and Resistance to Combined BRAF and MEK Inhibitors in Melanoma.
Molecular Cancer Therapeutics
Sanchez, Ileine M IM; Purwin, Timothy J TJ; Chervoneva, Inna I; Erkes, Dan A DA; Nguyen, Mai Q MQ; Davies, Michael A MA; Nathanson, Katherine L KL; Kemper, Kristel K; Peeper, Daniel S DS; Aplin, Andrew E AE